Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-29

Clinical Trial Update: FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology [NA]

View source ↗

Summary

A completed clinical trial evaluating Electrographic Flow Mapping Technology (EGF) for persistent atrial fibrillation, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cortex | Conditions: Atrial Fibrillation, Persistent | NA | Status: COMPLETED | Results posted: 2025-01-29